Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
129
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease

Qing Ya WangDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
,
Yuan LiDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Ze Yin LiangDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
,
Yue YinDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
,
Wei LiuDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
,
Qian WangDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6379-4205
ORCID Icon,
Yu Jun DongDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
,
Yu Hua SunDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-9425-5597
ORCID Icon,
Wei Lin XuDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
&
Han Yun RenDepartment of Hematology, Peking University First Hospital, Peking University, Beijing, People’s Republic of China
 show all
Pages 10195-10203 | Published online: 04 Dec 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Weilai Xu, Li Ye, Chen Mei, Xin-ping Zhou, Yanling Ren, Liya Ma, Xinnong Ye, Chenxi Lu, Jie Jin & Hong-yan Tong. (2021) Decitabine combined with low dose idarubicin and cytarabine (D-IA) followed by allo-HSCT improves acute myeloid leukemia and higher-risk myelodysplastic syndrome patient outcomes: results from a retrospective study. Leukemia & Lymphoma 62:8, pages 1920-1929.
Read now

Articles from other publishers (13)

Qingya Wang, Zeyin Liang, Hanyun Ren, Yujun Dong, Yue Yin, Qingyun Wang, Wei Liu, Bingjie Wang, Na Han, Yangliu Li & Yuan Li. (2023) Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. Annals of Hematology 102:11, pages 3061-3074.
Crossref
Jinye Zhu, Qian Wang, Yongjia Liu, Yujun Dong, Zeyin Liang, Yue Yin, Wei Liu, Weilin Xu, Yuhua Sun, Bingjie Wang, Qingyun Wang, Qingya Wang, Na Han, Hanyun Ren & Yuan Li. (2023) High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant. International Immunopharmacology 120, pages 110299.
Crossref
Xiwen Tong, Mengyuan Li, Jie Jin, Yi Li, Li Li, Yizhou Peng, Lifang Huang, Bin Xu, Fankai Meng, Xia Mao, Liang Huang, Wei Huang & Donghua Zhang. (2023) Cladribine‐ and decitabine‐containing conditioning regimen has a low post‐transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. International Journal of Cancer 152:10, pages 2123-2133.
Crossref
Yuan Yuan Shi, Long Su, Zeng Yan Liu, Yi Geng Cao, Xin Chen, Rong Li Zhang, Qing Zhen Liu, Jian Feng Yao, Wei Hua Zhai, Qiao Ling Ma, Er Lie Jiang & Ming Zhe Han. (2023) A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with Prognosis. Chemotherapy 68:3, pages 143-154.
Crossref
Guancui Yang, Xiang Wang, Shiqin Huang, Ruihao Huang, Jin Wei, Xiaoqi Wang & Xi Zhang. (2022) Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy. Frontiers in Immunology 13.
Crossref
Yuxin Wang, Yao Sun, Jing Xie, Jiangwei Hu, Na Liu, Jianlin Chen, Botao Li, Sanchun Lan, Jingwen Niu, Lei Wang, Zhuoqing Qiao, Yu Zhang, Jing Ren, Bin Zhang, Liren Qian, Yehui Tan, Liping Dou, Yuhang Li & Liangding Hu. (2022) Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study. Frontiers in Oncology 12.
Crossref
Ran Zhang, Xuan Lu, Liang V. Tang, Hua-Fang Wang, Han Yan, Yong You, Zhao-Dong Zhong, Wei Shi & Ling-Hui Xia. (2022) Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 57:7, pages 1063-1071.
Crossref
Ziying Li, Wei Shi, Xuan Lu, Hui Lu, Xiena Cao, Liang Tang, Han Yan, Zhaodong Zhong, Yong You, Linghui Xia, Yu Hu & Huafang Wang. (2022) Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis. Frontiers in Oncology 12.
Crossref
Qing Ya Wang, Hui Hui Liu, Yu Jun Dong, Ze Yin Liang, Yue Yin, Wei Liu, Qing Yun Wang, Qian Wang, Yu Hua Sun, Wei Lin Xu, Na Han, Yuan Li & Han Yun Ren. (2022) Low-Dose 5-Aza and DZnep Alleviate Acute Graft-Versus-Host Disease With Less Side Effects Through Altering T-Cell Differentiation. Frontiers in Immunology 13.
Crossref
Guangjie Zhao, Qian Wang, Shuang Li & Xiaoqin Wang. (2021) Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism. Frontiers in Oncology 11.
Crossref
Giuditta Benincasa, Maria Vasco, Alessio Corrado, Annunziata Sansone, Antonietta Picascia & Claudio Napoli. (2021) Epigenetic‐based therapy in allogenic hematopoietic stem cell transplantation: Novel opportunities for personalized treatment. Clinical Transplantation 35:8.
Crossref
Rui Zhang, Lili Wang, Peng Chen, Xiaoning Gao, Shuhong Wang, Fei Li, Liping Dou, Chunji Gao, Yan Li & Daihong Liu. (2021) Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study. Cancer Medicine 10:10, pages 3165-3176.
Crossref
Christopher R. D’Angelo, Aric Hall, Kaitlin M. Woo, KyungMann Kim, Walter Longo, Peiman Hematti, Natalie Callander, Vaishalee P. Kenkre, Ryan Mattison & Mark Juckett. (2020) Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. Leukemia Research 96, pages 106419.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.